688677.SH
海泰新光
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 84.25
−8.35%Year over year
Reported trailing growth
- Revenue
- +33.5%
- EBITDA
- —
- EBIT
- +17.3%
- EPS
- +20.8%
- Free cash flow
- +90.0%
- Operating cash flow
- +3.6%
Forward estimates
Based on analyst estimates
- Revenue
- +2.6%
- EBITDA
- -0.8%
- EPS
- -9.1%
Three-year CAGR
- Revenue
- +8.1%
- EBITDA
- +0.7%
- EBIT
- -2.7%
- Net income
- -2.2%
- EPS
- -1.4%
- Free cash flow
- +266.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026